Lyra Capital Overview
- Founded
-
1999
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
2
Lyra Capital General Information
Description
Provider of asset management services.. The company creates, markets, and manages investable hedge fund index products, and specifically manages the Dow Jones Institutional Benchmark Series. It delivers the returns of specific hedge fund strategies without the allocation, leverage, and operational risks associated with many hedge fund structures. It conducts manager due diligence and negotiates transparency and other key terms with managers.
Contact Information
Website
www.lyracapital.com
Formerly Known As
Zurich Institutional Benchmarks Management
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Asset Management
Primary Office
- 1301 Avenue of the Americas
- 38th Floor
- New York, NY 10019
- United States
Lyra Capital Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lyra Capital Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lyra Capital Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 14-Feb-2022 | 00000 0000 | 00000 | Drug Discovery | |
| Teradici | 25-Feb-2016 | Mezzanine | 00.00 | Systems and Information Management |
Lyra Capital Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 00000000 | 25-Feb-2016 | 000000000 | 00.00 | Completed |
|